Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 12Neurofibroma, Plexiform 6Carcinoma, Non-Small-Cell Lung 4Neurofibrosarcoma 3Neoplasms 3Lung Neoplasms 3Melanoma 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Pancreatic Neoplasms 1Pain 1Neoplasm Metastasis 1Muscle Invasive Bladder Cancer 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Gallbladder Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

Acetaminophen 4Surveys and Questionnaires 3Saline Solution 3nabiximols 2Standard of Care 2Radiofrequency Ablation 2Oxycodone 2Music Therapy 2Morphine 2Methods 2Electroacupuncture 2Dronabinol 2siltuximab 1pegfilgrastim 1oxycodone-acetaminophen 1erenumab 1Yoga 1Xylitol 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Telemedicine 1STAMP-I protocol 1Remifentanil 1Range of Motion, Articular 1Psychiatric Rehabilitation 1Preoperative Exercise 1Physical Therapy Modalities 1Pentoxifylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × AZD 6244 × 1 year × Clear all
NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡